HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.

AbstractBACKGROUND:
Emergency department (ED) management of hereditary angioedema (HAE) has been hindered by misdiagnosis and limited treatment options. Food and Drug Administration approval of 4 on-demand HAE therapies starting in 2009 and the publication of ED guidelines for angioedema management in 2014 should facilitate improvement of HAE management in the ED.
OBJECTIVE:
The objective of this study was to identify patient-reported areas for improvement in ED management of HAE attacks.
METHODS:
Patients with self-reported HAE with C1 inhibitor deficiency who attended the 2015 HAE Association Patient Summit were asked to complete an anonymous 30-question survey. Questions addressed patient characteristics and HAE management in the ED.
RESULTS:
Patients indicated that understanding of HAE in the ED needed improvement (99%, 104 of 105 patients). Recognition of HAE as a diagnosis (48%, 50 of 105 patients), appreciation of HAE as a serious disease (45%, 47 of 105 patients), and medication management (59%, 62 of 105 patients) were identified as areas needing improvement. Among 39 patients who required ED care within the last year, 6 did not receive any HAE-targeted therapy, and treatment with corticosteroids (n = 3), epinephrine (n = 2), and antihistamines (n = 7) was reported. Among 68 patients whose treatment plan was to receive home on-demand therapy, 26 required ED care because of an inability to receive on-demand therapy at home as outlined in their treatment plan. Having a treatment plan was associated with a greater likelihood of receiving HAE therapy in the ED (99% vs 74%, P = .002).
CONCLUSION:
HAE management in the ED can be improved with a focus on recognition of HAE attacks and administration of effective HAE therapies.
AuthorsIris M Otani, Sandra C Christiansen, Paula Busse, Carlos A Camargo Jr, Bruce L Zuraw, Marc A Riedl, Aleena Banerji
JournalThe journal of allergy and clinical immunology. In practice (J Allergy Clin Immunol Pract) 2017 Jan - Feb Vol. 5 Issue 1 Pg. 128-134.e4 ISSN: 2213-2201 [Electronic] United States
PMID27665386 (Publication Type: Journal Article)
CopyrightCopyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Topics
  • Adolescent
  • Angioedemas, Hereditary (diagnostic imaging, epidemiology, therapy)
  • Child
  • Child, Preschool
  • Diagnostic Errors
  • Disease Management
  • Emergency Medical Services
  • Emergency Service, Hospital
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Patient Satisfaction
  • Practice Guidelines as Topic
  • Quality Assurance, Health Care
  • Quality Improvement
  • Surveys and Questionnaires
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: